For instance, the co-occurrence of APOB1 and CTNNB1 mutations and the co-mutation of TP53 and MUC4 were observed in sample sets containing only 6 and 5 HCC patients, respectively (Supplementary Figures S3A,B). Here, TP53 is linked to hepatocellular carcinoma.